361 related articles for article (PubMed ID: 34731857)
21. Randomized controlled trial of mycophenolate mofetil in children, adolescents, and adults with IgA nephropathy.
Hogg RJ; Bay RC; Jennette JC; Sibley R; Kumar S; Fervenza FC; Appel G; Cattran D; Fischer D; Hurley RM; Cerda J; Carter B; Jung B; Hernandez G; Gipson D; Wyatt RJ
Am J Kidney Dis; 2015 Nov; 66(5):783-91. PubMed ID: 26209543
[TBL] [Abstract][Full Text] [Related]
22. Treatment protocol with pulse and oral steroids for IgA Nephropathy after kidney transplantation.
Messina M; di Vico MC; Ariaudo C; Mazzucco G; Fop F; Segoloni GP; Biancone L
J Nephrol; 2016 Aug; 29(4):575-83. PubMed ID: 27217158
[TBL] [Abstract][Full Text] [Related]
23. Steroid therapy in children with IgA nephropathy.
Cambier A; Boyer O; Deschenes G; Gleeson J; Couderc A; Hogan J; Robert T
Pediatr Nephrol; 2020 Mar; 35(3):359-366. PubMed ID: 30778826
[TBL] [Abstract][Full Text] [Related]
24. Corticosteroids in the treatment of IgA nephropathy: lessons from the TESTING trial.
Zhang Y; Hu YT; Lv JC; Zhang H
Pediatr Nephrol; 2023 Oct; 38(10):3211-3220. PubMed ID: 36881171
[TBL] [Abstract][Full Text] [Related]
25. Combination therapy of low-dose cyclosporine and steroid in adults with IgA nephropathy
.
Ihm HS; Lee JY; Hwang HS; Kim YG; Moon JY; Lee SH; Jeong KH; Lee TW; Ihm CG
Clin Nephrol; 2019 Sep; 92(3):131-140. PubMed ID: 31232271
[TBL] [Abstract][Full Text] [Related]
26. Combined treatment with steroids and azathioprine in IgA nephropathy: design of a prospective randomised multicentre trial.
Locatelli F; Pozzi C; Del Vecchio L; Andrulli S; Pani A; Fogazzi G; Altieri P; Ponticelli C
J Nephrol; 1999; 12(5):308-11. PubMed ID: 10630693
[TBL] [Abstract][Full Text] [Related]
27. Comparison of steroid-pulse therapy and combined with mizoribine in IgA nephropathy: a randomized controlled trial.
Masutani K; Tsuchimoto A; Yamada T; Hirakawa M; Mitsuiki K; Katafuchi R; Hirakata H; Kitazono T; Tsuruya K;
Clin Exp Nephrol; 2016 Dec; 20(6):896-903. PubMed ID: 26758039
[TBL] [Abstract][Full Text] [Related]
28. Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy.
Barratt J; Lafayette R; Kristensen J; Stone A; Cattran D; Floege J; Tesar V; Trimarchi H; Zhang H; Eren N; Paliege A; Rovin BH;
Kidney Int; 2023 Feb; 103(2):391-402. PubMed ID: 36270561
[TBL] [Abstract][Full Text] [Related]
29. Steroids and azathioprine in the treatment of IgA nephropathy.
Stangou M; Ekonomidou D; Giamalis P; Liakou H; Tsiantoulas A; Pantzaki A; Papagianni A; Efstratiadis G; Alexopoulos E; Memmos D
Clin Exp Nephrol; 2011 Jun; 15(3):373-380. PubMed ID: 21301920
[TBL] [Abstract][Full Text] [Related]
30. Tonsillectomy and corticosteroid therapy with concomitant methylprednisolone pulse therapy for IgA nephropathy.
Suwabe T; Ubara Y; Sogawa Y; Higa Y; Nomura K; Nakanishi S; Hoshino J; Sawa N; Katori H; Takemoto F; Hara S; Ohashi K; Takaichi K
Contrib Nephrol; 2007; 157():99-103. PubMed ID: 17495444
[TBL] [Abstract][Full Text] [Related]
31. Should we really STOP treating patients with IgA nephropathy with steroids?
Locatelli F; Del Vecchio L; Ponticelli C
Physiol Int; 2018 Jun; 105(2):101-109. PubMed ID: 29975121
[TBL] [Abstract][Full Text] [Related]
32. A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy.
Wheeler DC; Toto RD; Stefánsson BV; Jongs N; Chertow GM; Greene T; Hou FF; McMurray JJV; Pecoits-Filho R; Correa-Rotter R; Rossing P; Sjöström CD; Umanath K; Langkilde AM; Heerspink HJL;
Kidney Int; 2021 Jul; 100(1):215-224. PubMed ID: 33878338
[TBL] [Abstract][Full Text] [Related]
33. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
Pozzi C; Andrulli S; Pani A; Scaini P; Roccatello D; Fogazzi G; Pecchini P; Rustichelli R; Finocchiaro P; Del Vecchio L; Locatelli F
J Nephrol; 2013; 26(1):86-93. PubMed ID: 22460183
[TBL] [Abstract][Full Text] [Related]
34. Corticosteroid therapy in IgA nephropathy.
Lv J; Xu D; Perkovic V; Ma X; Johnson DW; Woodward M; Levin A; Zhang H; Wang H;
J Am Soc Nephrol; 2012 Jun; 23(6):1108-16. PubMed ID: 22539830
[TBL] [Abstract][Full Text] [Related]
35. A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy.
Lafayette R; Barbour S; Israni R; Wei X; Eren N; Floege J; Jha V; Kim SG; Maes B; Phoon RKS; Singh H; Tesař V; Lin CJF; Barratt J
Kidney Int; 2024 Jun; 105(6):1306-1315. PubMed ID: 38552841
[TBL] [Abstract][Full Text] [Related]
36. Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.
Rauen T; Eitner F; Fitzner C; Sommerer C; Zeier M; Otte B; Panzer U; Peters H; Benck U; Mertens PR; Kuhlmann U; Witzke O; Gross O; Vielhauer V; Mann JF; Hilgers RD; Floege J;
N Engl J Med; 2015 Dec; 373(23):2225-36. PubMed ID: 26630142
[TBL] [Abstract][Full Text] [Related]
37. Supportive Versus Immunosuppressive Therapy of Progressive IgA nephropathy (STOP) IgAN trial: rationale and study protocol.
Eitner F; Ackermann D; Hilgers RD; Floege J
J Nephrol; 2008; 21(3):284-9. PubMed ID: 18587715
[TBL] [Abstract][Full Text] [Related]
38. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL; Radhakrishnan J; Alpers CE; Barratt J; Bieler S; Diva U; Inrig J; Komers R; Mercer A; Noronha IL; Rheault MN; Rote W; Rovin B; Trachtman H; Trimarchi H; Wong MG; Perkovic V;
Lancet; 2023 May; 401(10388):1584-1594. PubMed ID: 37015244
[TBL] [Abstract][Full Text] [Related]
39. Prospective randomized controlled multicenter trial on steroids plus ramipril in proteinuric IgA nephropathy.
Manno C; Gesualdo L; D'Altri C; Rossini M; Grandaliano G; Schena FP
J Nephrol; 2001; 14(4):248-52. PubMed ID: 11506246
[TBL] [Abstract][Full Text] [Related]
40. Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis.
Inker LA; Mondal H; Greene T; Masaschi T; Locatelli F; Schena FP; Katafuchi R; Appel GB; Maes BD; Li PK; Praga M; Del Vecchio L; Andrulli S; Manno C; Gutierrez E; Mercer A; Carroll KJ; Schmid CH; Levey AS
Am J Kidney Dis; 2016 Sep; 68(3):392-401. PubMed ID: 27032886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
